Respiratory Trials·org

Pulmonary embolism · Ruling out pulmonary embolism

ADJUST-PE management cohort

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism

ADJUST-PE trial design and results
Design Multicentre prospective management study
Treatment Age-adjusted D-dimer cutoff of age × 10 µg/L in patients over 50
Control Fixed D-dimer cutoff of 500 µg/L
Population 3346 patients with suspected pulmonary embolism, prevalence of PE 19%
Follow-up 3 months
Primary endpoint Failure rate — venous thromboembolism during follow-up after exclusion
Result Among 2898 patients with non-high clinical probability, 817 (28.2%) had D-dimer below 500 µg/L and 337 (11.6%) fell between 500 µg/L and their age-adjusted cutoff. The 3-month failure rate in that intermediate band was 1 of 331 (0.3%, 95% CI 0.1% to 1.7%). In patients 75 or older with non-high probability, the age-adjusted cutoff raised the proportion in whom PE could be excluded from 6.4% to 29.7% with no additional false negatives.
Secondary endpoints Proportion of older patients in whom imaging was avoided

Compared with a fixed D-dimer cutoff of 500 µg/L, the combination of pretest clinical probability assessment with age-adjusted D-dimer cutoff was associated with a larger number of patients in whom PE could be considered ruled out with a low likelihood of subsequent clinical venous thromboembolism.

The trial authors, in the published abstract

How it has aged

Solves a specific and common problem: D-dimer rises with age, so the fixed threshold excludes almost nobody over 75. Raising it turned a useless test into a useful one in exactly the group most likely to be harmed by contrast and radiation. Superseded in many units by YEARS or PEGeD, which achieve the same end differently.

Publications

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study

Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014 Mar 19;311(11):1117-24.

  • Proportion of over-75s in whom PE could be excluded rose from 6.4% to 29.7%
  • 3-month failure rate in the age-adjusted band 0.3%
  • No additional false-negative findings